AirPhysio Pty Ltd is an Australian health care startup that focuses on developing and manufacturing an OPEP (Oscillating Positive Expiratory Pressure) device aimed at improving respiratory health. The company, based in regional NSW (Tweed Heads and Maitland), has gained recognition for its innovative design and high-quality construction, using the finest polycarbonate materials. With a strong global presence, AirPhysio has successfully penetrated markets in the USA, Canada, the UK, and South East Asia, selling tens of thousands of devices worldwide. The award-winning AirPhysio device offers relief for respiratory conditions such as asthma, COPD, bronchiectasis, and cystic fibrosis, providing a natural and effective method for expelling mucus and contaminants from the lungs. The device requires only 5-10 minutes of daily usage to yield significant benefits, making it an attractive solution for individuals seeking non-invasive respiratory treatments. As the demand for AirPhysio's product continues to surge, the company is experiencing considerable growth and interest from potential investors. With its strong market position and increasing recognition in respiratory health, AirPhysio presents an appealing investment opportunity for venture capitalists seeking exposure to the burgeoning health care industry. For more information on investment opportunities and the company's product, interested parties are encouraged to visit AirPhysio's website and social media channels.
There is no investment information
No recent news or press coverage available for AirPhysio Pty Ltd.